コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ective shotgun metagenomic analyses of human gastrointestinal microbiota.
2 species) from 31 families found in the human gastrointestinal microbiota.
3 esource to facilitate investigation of human gastrointestinal microbiota.
4 testinal epithelium, host immune system, and gastrointestinal microbiota.
5 hat affect the size and composition of their gastrointestinal microbiota.
6 e of inflammation, lipid metabolism, and the gastrointestinal microbiota.
7 n supraorganismal system, which includes the gastrointestinal microbiota.
8 g infant and instead targeted to its cognate gastrointestinal microbiota.
9 ffin and mast cells, enteric nerves, and the gastrointestinal microbiota.
10 ch of which involves an interaction with the gastrointestinal microbiota.
11 ew its application to the study of the human gastrointestinal microbiota.
12 nce H. pylori eradication and to restore the gastrointestinal microbiota.
13 on chemotherapy, on antibiotic resistance in gastrointestinal microbiota after completion of inductio
14 mmune and oxidative stress-related pathways, gastrointestinal microbiota alterations, and some cognit
17 ion of the impact of dietary intervention on gastrointestinal microbiota and metabolites after alloge
19 e effective through their impact on the host gastrointestinal microbiota and promotion of mucosal imm
20 nflammatory bowel disease (IBD) involves the gastrointestinal microbiota and some evidence that the m
21 e complex and bidirectional networks between gastrointestinal microbiota and their host, highlighting
22 in the gut generally show alterations in the gastrointestinal microbiota, and changes during weight l
23 en patient characteristics, medications, the gastrointestinal microbiota, and CRPA colonization acqui
24 include genetic associations, alterations in gastrointestinal microbiota, and disturbances in mucosal
25 itigation of colitis, maintenance of healthy gastrointestinal microbiota, and protected gut mucosal b
26 microbiome, potential interactions with the gastrointestinal microbiota, and the possibilities for m
29 li is a frequent member of the healthy human gastrointestinal microbiota, as well as an important hum
31 and essential micronutrients, as well as the gastrointestinal microbiota, can change the balance betw
32 ration.These results indicate that the human gastrointestinal microbiota composition and function var
33 ment of our current understanding of how the gastrointestinal microbiota contributes to food allergy
35 Here we show that secretory products from gastrointestinal microbiota derived from a human donor s
36 ntify previously unidentified alterations in gastrointestinal microbiota-derived short-chain fatty ac
38 eveloped a mouse model of antibiotic-induced gastrointestinal microbiota disruption that is character
43 formation by plant enzymes or enzymes of the gastrointestinal microbiota give rise to biologically ac
45 tabolites into the bloodstream(5,6), and the gastrointestinal microbiota has also been reported to ex
51 s growing appreciation for the importance of gastrointestinal microbiota in many physiological and pa
52 ffects of dupilumab on the nasal passage and gastrointestinal microbiota in patients with diffuse typ
53 ion may result in deleterious effects on the gastrointestinal microbiota, including reductions in bif
54 set the groundwork for interpreting how the gastrointestinal microbiota influence the health of the
56 is evolving that species composition of the gastrointestinal microbiota is a polygenic trait governe
59 ess incidence, how these products impact the gastrointestinal microbiota is not completely understood
62 dings highlighting the interplay between the gastrointestinal microbiota, its host and bacterial path
63 letion, and reestablishment of a physiologic gastrointestinal microbiota might be beneficial for this
64 ins elusive; however, it's hypothesized that gastrointestinal microbiota might play an important role
65 isceral hypersensitivity, and alterations in gastrointestinal microbiota, mucosal and immune function
69 imed to identify microbial signatures in the gastrointestinal microbiota preceding NEC diagnosis in p
71 characterizing the constituents of the human gastrointestinal microbiota, such as Helicobacter pylori
72 roides comprises canonical commensals of the gastrointestinal microbiota that maintain intestinal hom
73 ition that may be associated with an altered gastrointestinal microbiota that promotes an immune envi
74 what is known to date with respect to human gastrointestinal microbiota - the niche which has been m
75 cted profoundly by the ability to modify the gastrointestinal microbiota through the rational deploym
76 iceptive influences; the contribution by the gastrointestinal microbiota to this balance has received